Venclexta

Active Ingredient(s): Venetoclax
FDA Approved: * April 11, 2016
Pharm Company: * ABBVIE INC
Category: Cancer

Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML).[3][4] The most common side effects are low levels of neutrophils (a type of white blood cell), diarrhea, nausea, anemia (low red blood cell counts), nose and throat infection and tiredness.[4] Venetoclax attaches to a protein called Bcl-2.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Venclexta 10 mg Oral Tablet, Film Coated
NDC: 0074-0561
Labeler:
Abbvie Inc.
Venclexta 50 mg Oral Tablet, Film Coated
NDC: 0074-0566
Labeler:
Abbvie Inc.
Venclexta 100 mg Oral Tablet, Film Coated
NDC: 0074-0576
Labeler:
Abbvie Inc.
Venclexta Kit
NDC: 0074-0579
Labeler:
Abbvie Inc.